MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells

Cisplatin chemoresistance is a clinical obstacle in the treatment of gastric cancer (GC). Enhanced DNA repair capacity may lead to cisplatin resistance. However, the detailed molecular mechanism of GC cisplatin resistance specifically involving nucleotide excision repair (NER) is not clear. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiaoque, Huang, Nana, Zhang, Yiyin, Wei, Xiaoli, Gao, Mengru, Li, Min, Ning, Jie, Liu, Wei, Zhao, Qihong, Wang, Hua, Gu, Kangsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400793/
https://www.ncbi.nlm.nih.gov/pubmed/30854110
http://dx.doi.org/10.7150/jca.25814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400793/
https://www.ncbi.nlm.nih.gov/pubmed/30854110
http://dx.doi.org/10.7150/jca.25814

Ejemplares similares